Leading brokers name 3 ASX shares to sell today

Leading brokers have named Bubs Australia Ltd (ASX:BUB) and these ASX shares as sells this week. Here's why they are bearish…

| More on:
Business man marking Sell on board and underlining it

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Monday I looked at three ASX shares that brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here's why these brokers are bearish on these ASX shares:

Bubs Australia Ltd (ASX: BUB)

According to a note out of Citi, its analysts have retained their sell rating and 35 cents price target on this infant formula company. This follows the release of a mixed third quarter update last week. The broker continues to believe that Bubs is in a difficult spot due to challenging market conditions in China which is seeing domestic players outperforming. Especially given how small its brand is. Furthermore, it feels that China's declining birth rate means the market could contract in the near future. The Bubs share price is trading at 40 cents today.

Paradigm Biopharmaceuticals Ltd (ASX: PAR)

A note out of Morgans reveals that its analysts have retained their reduce rating and $1.69 price target on this biopharmaceutical company's shares. According to the note, the broker wasn't surprised to see the US FDA put Paradigm's investigational new drug (IND) application on hold. Morgans believes that a decision could be months away, which will lead to further cash burn and uncertainty. The broker has previously stated that it sees risk to the viability of the company's osteoarthritis drug as a commercial asset. The Paradigm share price is fetching $2.33 today.

Premier Investments Limited (ASX: PMV)

Analysts at Goldman Sachs have retained their sell rating and $20.20 price target on this retail conglomerate's shares. This follows an update on its JobKeeper payment and guidance for FY 2021. According to the note, Premier Investments' earnings before interest and tax guidance of $318 million is largely in line with its estimates. However, this doesn't change its view on the company. With Goldman expecting its earnings to fall materially in FY 2022 and then remain flat into FY 2023, it feels its shares are expensive at the current level. The Premier Investments share price is trading at $26.12 this afternoon.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of BUBS AUST FPO. The Motley Fool Australia owns shares of and has recommended Premier Investments Limited. The Motley Fool Australia has recommended BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

young woman reviewing financial reports at desk with multiple computer screens
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

Read more »

Woman in celebratory fist move looking at phone
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

These ASX 200 shares could rise 20% to almost 30%

Analysts are tipping these shares to deliver big returns over the next 12 months.

Read more »

Two people tired and resting after sports race.
Broker Notes

Fundie rates 2 ASX 200 stocks in short-term pain but with long-term gain potential

Blackwattle Investment Partners sees these 2 ASX 200 stocks as worthy of a buy and hold strategy.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Guess which beaten down ASX share is rocketing 11% today

Why are investors buying this beaten down stock? Let's find out.

Read more »

Broker working with share prices on computers.
Broker Notes

These 3 ASX All Ords stocks just got sizeable broker upgrades

Top brokers expect strong performance from these ASX All Ords stocks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Morgans says these ASX 200 stocks can rise 30%

Big returns could be on the cards for buyers of these shares.

Read more »